Correlation Between Multicell Techs and Defence Therapeutics

Can any of the company-specific risk be diversified away by investing in both Multicell Techs and Defence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Multicell Techs and Defence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Multicell Techs and Defence Therapeutics, you can compare the effects of market volatilities on Multicell Techs and Defence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Multicell Techs with a short position of Defence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Multicell Techs and Defence Therapeutics.

Diversification Opportunities for Multicell Techs and Defence Therapeutics

0.0

Correlation Coefficient

Multicell Techs  Defence Therapeutics

Pay attention - limited upside

The 3 months correlation between Multicell and Defence is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Multicell Techs and Defence Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Defence Therapeutics and Multicell Techs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Multicell Techs are associated (or correlated) with Defence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Defence Therapeutics has no effect on the direction of Multicell Techs i.e., Multicell Techs and Defence Therapeutics go up and down completely randomly.

Pair Corralation between Multicell Techs and Defence Therapeutics

If you would invest  40.00  in Defence Therapeutics on September 13, 2024 and sell it today you would earn a total of  1.00  from holding Defence Therapeutics or generate 2.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Multicell Techs  vs.  Defence Therapeutics

Multicell Techs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Multicell Techs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Multicell Techs is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Defence Therapeutics

Risk-Adjusted Performance

2 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Defence Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Defence Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Multicell Techs and Defence Therapeutics

The main advantage of trading using opposite Multicell Techs and Defence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Multicell Techs position performs unexpectedly, Defence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Defence Therapeutics will offset losses from the drop in Defence Therapeutics' long position.

The idea behind Multicell Techs and Defence Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.